Trial Profile
Ticagrelor vs. clopidogrel in patients undergoing implantation of paclitaxel-eluting stents in the femoropopliteal district: a randomized, nested pilot study using Frequency-Domain Optical Coherence Tomography (FD-OCT)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2018
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel
- Indications Chronic limb-threatening ischemia; Peripheral arterial disorders; Peripheral ischaemia
- Focus Therapeutic Use
- 29 Aug 2018 Primary endpoint (Net percentage volume obstruction assessed by Frequency-Domain -Optical Coherence Tomography) has not been met, according to results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology.
- 29 Aug 2018 Status changed from recruiting to completed according to results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology.
- 29 Aug 2018 Results presented at the ESC Congress 2018: Annual Congress of the European Society of Cardiology.